Levofloxacin Dosing for Acute Bacterial Sinusitis
For acute bacterial sinusitis in otherwise healthy adults, levofloxacin should be dosed at either 750 mg once daily for 5 days OR 500 mg once daily for 10-14 days, with both regimens demonstrating equivalent efficacy. 1, 2
Standard Dosing Regimens
The FDA-approved dosing options for acute bacterial sinusitis are 1:
- High-dose, short-course: 750 mg orally once daily for 5 days
- Standard regimen: 500 mg orally once daily for 10-14 days
Both regimens achieve clinical success rates exceeding 90% against the typical pathogens (Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis) 2. A multicenter trial demonstrated that the 750 mg for 5 days regimen is non-inferior to 500 mg for 10 days, with similar safety profiles 2, 3.
When to Use Levofloxacin
Important caveat: Levofloxacin is NOT first-line therapy for acute bacterial sinusitis. Current guidelines recommend amoxicillin-clavulanate as the preferred agent, with respiratory fluoroquinolones (including levofloxacin) reserved as alternatives 4.
Use levofloxacin when:
- Patient has β-lactam allergy
- Patient has failed first-line therapy
- Patient has moderate disease with recent antibiotic use (within 4-6 weeks) 5
- Severe or complicated sinusitis (frontal, ethmoidal, or sphenoidal involvement) 6
Renal Dose Adjustments
Dosing adjustments are required when creatinine clearance (CrCl) falls below 50 mL/min 1:
| CrCl (mL/min) | Initial Dose | Subsequent Doses |
|---|---|---|
| 50-80 | No adjustment needed | No adjustment needed |
| 20-49 | 750 mg | 750 mg every 48 hours |
| 10-19 | 750 mg | 500 mg every 48 hours |
| Hemodialysis | 750 mg | 500 mg every 48 hours |
For the standard 500 mg regimen with CrCl 20-49 mL/min: give 500 mg initially, then 250 mg every 24 hours 1.
Recent evidence suggests that even patients with CrCl 50-89 mL/min may benefit from dose stratification, particularly when targeting higher pharmacodynamic targets for Gram-negative bacteria 7. However, current FDA labeling does not require adjustment until CrCl drops below 50 mL/min 1.
Practical Considerations
The high-dose, short-course regimen (750 mg for 5 days) offers several advantages:
- Maximizes concentration-dependent bacterial killing
- Improved patient compliance with shorter duration
- May reduce resistance development 8, 9
- Equivalent efficacy and safety to 10-day regimen 2, 3
Oral and IV formulations are bioequivalent, allowing seamless transition between routes without dose adjustment 10, 8, 9.
Critical Safety Warnings
Levofloxacin carries significant risks that must be weighed against benefits 1:
- Tendon rupture risk: Increased in patients >60 years, on corticosteroids, or with kidney/heart/lung transplants
- Peripheral neuropathy: Can be permanent
- CNS effects: Seizures, confusion, hallucinations
- QT prolongation: Avoid in elderly patients on Class IA/III antiarrhythmics
- Hepatotoxicity: Fatal cases reported, especially in patients ≥65 years
Discontinue immediately if patient develops tendon pain, peripheral neuropathy symptoms, or signs of hepatitis 1.
Antibiotic Stewardship Context
Most acute rhinosinusitis is viral and self-limited. Reserve antibiotics only for patients with 4:
- Persistent symptoms >10 days without improvement
- Severe symptoms (fever >39°C, purulent discharge, facial pain) for ≥3 consecutive days
- "Double sickening" (worsening after initial improvement)
The number needed to treat with antibiotics is 18 for rapid cure, while the number needed to harm is only 8 4. Most patients benefit more from supportive care, saline irrigation, and intranasal corticosteroids 4.